|
May 10
|
Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year
|
|
May 9
|
Evolus First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 8
|
Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Q1 2024 Evolus Inc Earnings Call
|
|
May 8
|
Evolus Inc (EOLS) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth and Strategic ...
|
|
May 7
|
Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 7
|
Evolus Inc (EOLS) Q1 2024 Earnings: Surpasses Revenue Estimates with Significant Growth
|
|
May 7
|
Evolus Reports First Quarter 2024 Results and Provides Business Update
|
|
May 3
|
The 15% return this week takes Evolus' (NASDAQ:EOLS) shareholders one-year gains to 59%
|
|
May 1
|
Green Thumb Industries Inc. (GTBIF) Surges 22.3%: Is This an Indication of Further Gains?
|
|
Apr 23
|
Evolus to Report First Quarter Financial Results on May 7, 2024
|
|
Apr 21
|
11 Best Low Price Pharma Stocks To Invest In
|
|
Apr 17
|
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra-Strength" 40U Formulation of Jeuveau®
|
|
Apr 6
|
Evolus, Inc. (NASDAQ:EOLS) is favoured by institutional owners who hold 57% of the company
|
|
Mar 26
|
Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 14
|
10 Stocks George Soros and Insiders Are Crazy About
|
|
Mar 13
|
Does Evolus, Inc. (EOLS) Have the Potential to Rally 63.24% as Wall Street Analysts Expect?
|
|
Mar 11
|
Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock
|
|
Mar 10
|
Analyst Estimates: Here's What Brokers Think Of Evolus, Inc. (NASDAQ:EOLS) After Its Full-Year Report
|
|
Mar 9
|
Evolus Full Year 2023 Earnings: In Line With Expectations
|